Samidorphan L-Malate
Drug Details
- Generic Name
- Samidorphan L-Malate
- Brand Names
- N/A
- Application Number
- Sponsor
- Cambrex Charles City, Inc
- NDC Codes
- 5
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- SAMIDORPHAN L-MALATE
Indications and Usage
1 INDICATIONS AND USAGE LYBALVI is indicated for the treatment of: Schizophrenia in adults Bipolar I disorder in adults Acute treatment of manic or mixed episodes as monotherapy and as adjunct to lithium or valproate Maintenance monotherapy treatment LYBALVI is a combination of olanzapine, an atypical antipsychotic, and samidorphan, an opioid antagonist, indicated for the treatment of: Schizophrenia in adults ( 1 ) Bipolar I disorder in adults ( 1 ) Acute treatment of manic or mixed episodes as monotherapy and as adjunct to lithium or valproate Maintenance monotherapy treatment